ArticleCancer immunology, immunotherapy : CII2026
TLR8 agonists remodel the tumor immune microenvironment through PF4-dependent T cell recruitment and ancillary mechanisms.
Qikai Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.